Revelation Biosciences REVB Growth Metrics (2020-2026)

NASDAQ REVB
$0.83 -0.03 (-3.64%)
As of: Sep 29, 2026 · 3:59 PM EDT
Reported Financials

Revelation Biosciences Quarterly Growth Metrics

Periods 23 quarters
Latest Jun 2026

Revelation Biosciences reported asset growth of 131.65% for the quarter ended Jun 2026. These growth metrics cover 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
2,002.15%-97.25%-89.22%-94.38%-91.03%169.48%127.06%286.11%115.38%121.91%-18.86%-23.50%-52.60%-45.78%-72.99%-56.03%90.74%74.91%278.92%131.65%
Assets Growth (3y)
59.58%-45.19%-41.66%-45.04%-54.92%48.01%-20.76%9.11%24.88%28.15%-6.01%-7.98%
Assets Growth (5y)
29.73%-31.02%-27.29%-29.91%
Assets (QoQ)
-0.45%-97.22%290.75%-47.95%58.92%-16.63%229.23%-11.48%-11.35%-14.11%20.38%-16.54%-45.07%-1.75%-40.04%35.89%138.30%-9.90%29.88%-16.93%
Capital Expenditures Growth (3y)Capex Growth (3y)
-42.16%-3.07%
Capital Expenditures Growth (5y)Capex Growth (5y)
-6.22%-4.16%
Capital Expenditures (QoQ)Capex (QoQ)
-200.01%-44.87%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
10,763.55%312.09%145.87%348.89%125.81%128.28%-17.53%-22.98%-53.28%-45.80%-74.63%-57.02%94.29%64.65%280.97%121.15%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
61.54%907.27%72.11%-19.87%14.11%27.03%26.76%-7.28%-9.88%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
30.78%290.83%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
464.83%-51.39%77.14%-15.27%237.01%-11.25%-10.89%-14.34%21.75%-17.12%-45.94%-0.64%-43.00%40.37%144.39%-15.80%31.90%-18.52%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
42.16%3.07%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
6.22%4.16%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
200.01%44.87%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-257,349.31%-1,283.33%-102.77%-3.21%22.52%67.09%67.39%46.32%0.85%-111.39%-80.17%-24.46%-439.24%-87.12%1.53%22.57%82.84%47.51%-15.05%-33.24%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-378.01%-1,155.23%-112.71%-6.01%11.66%-60.60%-9.19%16.67%19.73%2.82%-27.57%-26.85%-8.69%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-186.26%-349.28%-56.71%-6.18%6.59%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
37.84%-28.83%-67.77%23.18%53.34%45.28%-66.25%-26.44%13.80%-16.67%-41.70%12.66%-273.46%59.52%25.44%31.32%17.21%-23.80%-63.44%20.46%
EBIT Growth (1y)
-152.57%23.81%60.60%68.41%75.41%-3.90%-131.59%-90.91%-17.43%-30.49%35.32%24.59%-10.14%2.42%-8.14%-46.62%-47.61%-48.80%
EBIT Growth (3y)
9.98%-1.09%16.12%23.10%31.74%-9.78%-17.44%-28.28%-24.05%-23.74%
EBIT Growth (5y)
-3.47%-8.44%
EBIT (QoQ)
-24.66%-26.71%-70.76%71.75%35.53%-1.57%-32.96%-19.33%-43.71%16.27%18.22%-32.61%28.77%2.38%-19.45%-17.48%21.06%-32.35%-20.26%-18.42%
EBT Growth (1y)
-152.77%23.75%60.57%68.40%75.41%-3.90%-131.59%-90.91%-17.43%-30.49%35.32%24.59%-10.14%2.42%-8.14%-46.62%-47.61%-48.80%
EBT Growth (3y)
9.96%-1.11%16.10%23.09%31.74%-9.78%-17.44%-28.28%-24.05%-23.74%
EBT Growth (5y)
-3.49%-8.46%
EBT (QoQ)
-24.67%-26.75%-70.82%71.75%35.53%-1.57%-32.96%-19.33%-43.71%16.27%18.22%-32.61%28.77%2.38%-19.45%-17.48%21.06%-32.35%-20.26%-18.42%
EPS (Basic) Growth (1y)
407.66%100.17%67.55%-412,701.87%-187,976.46%-347,971.56%698.01%94.01%78.18%-329.94%-188.31%-1,959.15%-100.40%93.47%94.64%97.15%95.60%96.65%89.31%96.90%
EPS (Basic) Growth (3y)
925.25%-980.36%-196.16%-19.67%-1,620.74%-837.26%-892.74%34.32%67.25%73.20%78.89%-26.10%73.72%
EPS (Basic) Growth (5y)
-119.50%-156.63%43.65%60.33%-45.35%
EPS (Basic) (QoQ)
1.09%-36.75%-72,431.99%-792.15%53.97%-17.11%224.34%-108.94%-67.52%-2,208.04%74.46%-108.52%83.70%24.81%79.01%-10.64%74.77%42.82%33.02%67.97%
EPS (Diluted) Growth (1y)
-717,375.07%-219,021.57%-54,022.48%112.36%94.01%-419.23%-329.94%-225.28%-1,959.15%91.58%93.47%94.64%97.15%95.60%96.65%89.31%96.90%
EPS (Diluted) Growth (3y)
-1,968.91%-886.16%-435.25%79.75%67.25%73.20%78.89%-26.14%73.72%
EPS (Diluted) Growth (5y)
-57.85%
EPS (Diluted) (QoQ)
50.82%375.46%-382,630.36%73.85%53.97%-17.11%187.66%-112.69%-3,887.12%3.03%74.46%-108.52%83.70%24.81%79.01%-10.64%74.77%42.82%33.02%67.97%
Free Cash Flow Growth (1y)FCF Growth (1y)
-257,349.31%-1,275.56%-94.67%-1.82%22.52%66.90%67.39%46.32%0.85%-111.39%-81.39%-24.46%-440.27%-86.23%2.20%22.57%82.87%47.26%-17.62%-35.30%
Free Cash Flow Growth (3y)FCF Growth (3y)
-378.01%-1,155.23%-112.71%-4.82%12.05%-60.70%-9.22%16.67%19.73%2.82%-27.57%-27.79%-9.25%
Free Cash Flow Growth (5y)FCF Growth (5y)
-186.26%-349.28%-56.71%-5.78%6.55%
Free Cash Flow (QoQ)FCF (QoQ)
38.68%-28.11%-68.72%23.18%53.34%45.28%-66.25%-26.44%13.80%-16.67%-42.65%13.25%-274.18%59.78%25.08%31.32%17.21%-23.80%-67.09%20.99%
Net Cash Flow Growth (1y)NCF Growth (1y)
-167.28%-104.05%7.02%-1.82%221.70%67.08%110.60%46.32%-163.12%-112.51%-79.44%-24.46%-222.25%97.90%-209.15%22.57%236.20%-4,677.46%222.14%-37.06%
Net Cash Flow Growth (3y)NCF Growth (3y)
-36.03%-26.58%-22.61%12.05%-35.28%75.51%-35.23%19.73%40.45%-28.68%-35.04%-9.72%
Net Cash Flow Growth (5y)NCF Growth (5y)
17.80%-15.19%-9.18%6.31%
Net Cash Flow (QoQ)NCF (QoQ)
38.68%-28.11%306.50%-162.77%173.30%-134.65%1,420.98%-116.00%13.80%-16.67%227.82%-196.82%-123.18%99.24%-6,547.97%31.32%492.58%-126.65%269.96%-177.07%
Net Income Growth (1y)
-152.77%-39.76%-57.93%-0.33%75.41%-3.90%-131.59%-90.91%-17.43%-30.49%35.32%24.59%-10.14%2.42%-8.14%-46.62%-47.61%-48.80%
Net Income Growth (3y)
9.96%-23.75%-33.24%-13.04%31.74%-9.78%-17.44%-28.28%-24.05%-23.74%
Net Income Growth (5y)
-3.49%-22.43%
Net Income (QoQ)
42.94%-59.89%-442.39%71.75%35.53%-1.57%-32.96%-19.33%-43.71%16.27%18.22%-32.61%28.77%2.38%-19.45%-17.48%21.06%-32.35%-20.26%-18.42%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
313.48%100.07%-153.28%-100,191.98%-63,280.57%-103,136.35%193.09%21.07%-124.51%-82.42%-143.54%-479.34%14.72%21.66%23.51%32.94%-108.65%-45.50%-323.71%40.93%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
851.79%-1,346.74%-10.74%-0.87%-1,560.58%-966.10%-1,038.18%32.32%-45.28%-58.67%-27.64%-50.53%-31.90%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-210.04%-457.56%-9.13%-27.18%-348.52%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
1.09%-36.75%-564,651.28%72.27%36.19%-3.15%610.04%-123.51%-81.50%16.19%-21.72%-212.89%73.28%23.01%-18.85%-174.30%16.87%46.31%-246.10%61.76%
Operating Income Growth (1y)Op. Inc Growth (1y)
-152.57%23.81%60.60%68.41%75.41%-3.90%-131.59%-90.91%-17.43%-30.49%35.32%24.59%-10.14%2.42%-8.14%-46.62%-47.61%-48.80%
Operating Income Growth (3y)Op. Inc Growth (3y)
9.98%-1.09%16.12%23.10%31.74%-9.78%-17.44%-28.28%-24.05%-23.74%
Operating Income Growth (5y)Op. Inc Growth (5y)
-3.47%-8.44%
Operating Income (QoQ)Op. Inc (QoQ)
-24.66%-26.71%-70.76%71.75%35.53%-1.57%-32.96%-19.33%-43.71%16.27%18.22%-32.61%28.77%2.38%-19.45%-17.48%21.06%-32.35%-20.26%-18.42%
Profit After Tax Growth (1y)PAT Growth (1y)
-152.77%23.75%60.57%68.40%75.41%-3.90%-131.59%-90.91%-17.43%-30.49%35.32%24.59%-10.14%2.42%-8.14%-46.62%-47.61%-48.80%
Profit After Tax Growth (3y)PAT Growth (3y)
9.96%-1.11%16.10%23.09%31.74%-9.78%-17.44%-28.28%-24.05%-23.74%
Profit After Tax Growth (5y)PAT Growth (5y)
-3.49%-8.46%
Profit After Tax (QoQ)PAT (QoQ)
-24.67%-26.75%-70.82%71.75%35.53%-1.57%-32.96%-19.33%-43.71%16.27%18.22%-32.61%28.77%2.38%-19.45%-17.48%21.06%-32.35%-20.26%-18.42%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
-21.75%-23.00%-24.40%-25.99%-27.79%-7.01%-8.81%13.87%-13.45%-45.65%-50.31%-70.56%-67.93%231.96%389.14%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
-21.21%-26.99%-30.03%-37.16%-41.48%18.83%30.39%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-5.44%-5.75%-6.10%-6.50%-6.95%-7.47%-8.07%-8.78%19.84%-9.26%14.79%-30.66%-24.75%-17.03%-31.99%-24.47%678.86%22.25%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-0.02M0.01M0.01M0.02M0.01M-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-51.000.00M0.01M0.01M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.01M0.00M-136.000.01M0.01M-0.00M-0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-0.02M0.00M-0.00M0.00M0.01M0.00M-0.00M-0.00M-92.00-423.00-0.00M-0.00M-0.00M-0.00M0.01M0.00M-139.00-621.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-0.06M2.19M0.13M0.06M0.01M-0.04M-0.01M-0.01M-0.01M0.01M0.00M0.01M0.01M0.02M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.01M2.17M0.12M0.06M0.01M-0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
2.06M0.07M0.05M0.01M-0.00M-0.00M452.00-0.03M0.02M-0.00M-0.00M-0.01M0.01M0.00M411.00-0.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-0.03M0.56M0.06M-434.00-0.01M-0.04M-0.01M-0.01M-0.01M0.03M0.01M0.01M0.01M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.01M0.55M0.06M0.00M-0.00M
Return on Equity [ROE] (QoQ)ROE (QoQ)
0.50M0.06M0.01M-0.00M-0.00M104.00-0.01M-0.03M0.02M82.00-0.00M0.01M0.00M-82.00-546.00
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
34.76%-31.32%-69.03%-69.45%-76.72%-34.10%-21.09%-0.82%0.00%-46.00%0.00%126.10%596.25%-97.28%-97.28%410.11%110.78%45,881.33%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
-32.06%-37.48%-37.48%-11.84%17.46%-78.69%-72.20%125.32%144.83%89.02%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
35.71%25.04%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
0.00%-19.35%30.19%-34.60%-54.90%-20.44%-0.82%85.18%-46.00%0.00%0.00%0.00%0.00%126.10%207.93%-99.61%0.11%42,253.09%27.24%-14.77%

Revelation Biosciences Growth Metrics API

Pull Revelation Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=REVB&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY